Retina Macula

What Retina Macula does

Retina Macula Specialists of Miami is a privately held, founder-owned vitreoretinal medical practice headquartered in Miami-Dade County, Florida, operating three office locations across North Miami Beach, Miami (LeJeune Road), and Coral Gables. Founded by Dr. Wilfredo C. Lara and Dr. Jay Harris Levy, the practice delivers medical and surgical care for diseases of the retina, macula, and vitreous, including age-related macular degeneration, diabetic retinopathy, retinal detachment, macular holes, retinal vein occlusions, and epiretinal membranes. Services span diagnostic imaging (OCT, fundus photography, fluorescein and ICG angiography, B-scan ultrasound), office-based treatments (intravitreal injections of anti-VEGF and other agents, focal and panretinal laser photocoagulation, laser retinopexy, pneumatic retinopexy, and the FDA-authorized Valeda Light Delivery System for dry AMD), and surgical procedures (vitrectomy and scleral buckle).

The practice is staffed by three fellowship-trained vitreoretinal surgeons and one APRN, supported by 11-50 total employees. It generates revenue on a fee-for-service basis, accepting Medicare, Medicaid, virtually every South Florida HMO, and all major commercial insurance plans including Aetna, BCBS, Cigna, Humana, and United Healthcare. Patient acquisition runs through a formal physician referral program targeting primary care physicians, optometrists, and general ophthalmologists, supplemented by self-referral, online appointment requests, and a 24/7/365 call center. As a recognized clinical research site, the practice also participates as a principal investigator in national and international trials sponsored by Regeneron, Allergan, Alcon/Novartis, ThromboGenics, and the DRCR Network, providing early access to novel therapeutics.

The practice is bootstrapped with no disclosed outside investment, no parent company, and no acquisition history. Its competitive positioning rests on the subspecialty credentials of its physicians, three-location Miami-Dade footprint, clinical trial participation, and its self-claimed status as the largest private retina practice in Miami.

Name

Retina Macula

Legal name

Retina Macula Specialists of Miami

Website

https://retinamaculamiami.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Retina Macula Specialists of Miami is a private vitreoretinal medical practice in Miami-Dade County providing medical and surgical retina care, diagnostic imaging, anti-VEGF injections, laser therapy, and vitreoretinal surgery across three office locations, serving Medicare, Medicaid, and commercial insurance patients.

Ownership category

akta.pro rank

Product category

Ophthalmology / Vitreoretinal Healthcare Services

NAICS

Diagnostic Imaging Centers (621512), Offices of Optometrists (62132)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industries

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO)

Keywords

• Retinal disease treatment
• Vitreoretinal surgery
• Macular degeneration care
• Diabetic retinopathy treatment
• Ophthalmology services

Headquarters

HQ city

North Miami Beach

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical and Surgical Retina Services: Fee-for-service medical practice providing diagnostic examinations, intravitreal injections, laser treatments, and surgical procedures for vitreoretinal diseases. Revenue generated through medical consultations, diagnostic testing, and surgical interventions. Accepts Medicare, Medicaid, and all major private insurance plans.
2. Clinical Trial Participation: Participation in major national and international clinical trials for novel therapeutics development, contributing to advancement of retina care field while potentially receiving research funding.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Retina Macula Specialists of Miami provides medical and surgical management of vitreoretinal diseases, offering diagnostic imaging, intravitreal injections, retinal laser therapy, and advanced surgical procedures (vitrectomy, scleral buckle, pneumatic retinopexy) for conditions such as age-related macular degeneration, diabetic retinopathy, retinal detachment, and macular holes. The practice operates across three South Florida locations with 24/7 availability and participates in major national and international clinical trials.

Product overview

Retina Macula Specialists of Miami operates as a medical practice offering a comprehensive portfolio of vitreoretinal medical and surgical services. The practice provides diagnostic imaging services (Optical Coherence Tomography, Fundus Photography, Fluorescein Angiography, Indocyanine Green Angiography, B-Scan Ultrasound), treatment services (Intravitreal Injections with medications like Avastin, Lucentis, Eylea; Retinal Laser Treatments; Valeda Light Delivery System), and surgical procedures (Vitrectomy, Scleral Buckle, Pneumatic Retinopexy). The practice treats conditions including age-related macular degeneration, diabetic retinopathy, retinal detachment, retinal vein occlusions, macular holes, and epiretinal membranes.

Differentiator

Problem solved

Functional benefit

Products and services

• Vitreoretinal Medical and Surgical Services Comprehensive medical and surgical management of vitreoretinal diseases including diagnosis, treatment, and surgery of retina, macula, and vitreous conditions. Targeted at adult patients with retinal and macular conditions.
• Optical Coherence Tomography (OCT) Advanced diagnostic imaging technology used for detailed cross-sectional imaging of the retina to diagnose and monitor retinal conditions.
• Fundus Photography Photography-based diagnostic imaging of the retina used for documentation and monitoring of retinal diseases.
• Fluorescein Angiography Diagnostic imaging technique using fluorescein dye to visualize blood flow in the retina and identify vascular abnormalities.
• Indocyanine Green Angiography Diagnostic imaging using indocyanine green dye to examine blood vessels beneath the retina for detailed vascular assessment.
• B-Scan Eye Ultrasound Ultrasound imaging technique used to visualize internal structures of the eye when direct visualization is not possible.
• Intravitreal Injections Minimally invasive injection treatment delivering medications directly into the vitreous gel of the eye, including Avastin, Lucentis, Eylea, Jetrea, Triesence, Ozurdex, and Iluvien for various retinal conditions.
• Retinal Laser Treatments Laser-based treatments including Focal Laser Photocoagulation, Panretinal Laser Photocoagulation, and Laser Retinopexy for sealing leaking blood vessels and treating retinal conditions.
• Pneumatic Retinopexy Office-based procedure combining cryotherapy or laser photocoagulation with gas injection to reattach the retina for certain types of retinal detachment.
• Scleral Buckle Procedure Surgical procedure using a silicone band placed around the eye to support and reattach a detached retina.
• Vitrectomy Surgical procedure involving removal of the vitreous gel from the eye, replacement with air, gas, or silicone oil to repair retinal detachment, macular holes, and other vitreoretinal conditions.
• Valeda Light Delivery System FDA-authorized non-invasive, injection-free treatment system for dry age-related macular degeneration.

Quantifiable outcome

• High success rate for retinal detachment surgeries
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Diabetic Retinopathy Clinical Research NetworkcoreStrategic or Co-development PartnerClinical research collaboration focused on diabetic macular edema treatment studies, including Protocol V for central-involved diabetic macular edema in eyes with very good visual acuity.
• Astellas Pharma EuropeminorStrategic or Co-development PartnerPhase 2 clinical trial (VIDI) evaluating ASP8232 for reducing central retinal thickness in subjects with diabetic macular edema.
• Aerpio TherapeuticsminorStrategic or Co-development PartnerPhase 2 clinical trial evaluating AKB-9778 administered subcutaneously for diabetic macular edema treatment.
• ThromboGenicsminorStrategic or Co-development PartnerOcriplasmin (Jetrea) research study (ORBIT) to better inform treatment decisions.
• Nova Southeastern UniversityminorStrategic or Co-development PartnerPhase 1 research study (VAST) using optical coherence tomography to identify prevalence of vitreomacular adhesion and associated maculopathies.
• Alcon/NovartiscoreStrategic or Co-development PartnerTwo-year randomized clinical trial (HAWK) comparing RTH258 versus aflibercept for neovascular age-related macular degeneration.
• AllergancoreStrategic or Co-development PartnerClinical trial (SEQUOIA) evaluating safety and efficacy of abicipar pegol in patients with neovascular age-related macular degeneration.
• Regeneron PharmaceuticalscoreStrategic or Co-development PartnerPhase 2 clinical trial (ONYX) evaluating repeated doses of intravitreal REGN910-3 for neovascular age-related macular degeneration.
• OHR PharmaceuticalminorStrategic or Co-development PartnerPhase 3 clinical trial (MAKO) evaluating squalamine lactate ophthalmic solution for neovascular age-related macular degeneration.

Scale indicators2 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Retina Consultants of America: A network of leading retinal specialist practices across the U.S., comparable as a multi-location vitreoretinal medical and surgical group participating in clinical research and offering the same AMD, diabetic retinopathy, and retinal detachment services.
• Florida Retina Institute: A Florida-based vitreoretinal specialist practice offering medical and surgical retina care; comparable as a regional competitor in the same state with overlapping physician-referral dynamics.
• Tennessee Retina: Multi-location retinal specialty practice in Tennessee offering medical and surgical vitreoretinal care including clinical trial participation; comparable as a mid-size private retina group with similar service mix.
• Colorado Retina Associates: Denver-based vitreoretinal specialist group providing medical/surgical retina care and clinical research; comparable as a private subspecialty practice with similar payer mix and surgical offerings.
• Vance Thompson Vision: Midwest-based ophthalmology specialty group with a strong surgical and clinical research footprint; comparable as a private subspecialty eye-care practice participating in retina-focused clinical trials.
• Retinal Consultants of Arizona: Arizona-based vitreoretinal specialty group and member of Retina Consultants of America; comparable as a multi-physician retina practice offering advanced imaging, injections, and vitreoretinal surgery.

Broad incumbents

• EyeCare Partners: Large PE-backed ophthalmology and optometry platform providing medical, surgical, and vision care services; comparable as a multi-site operator offering retina care alongside broader eye-care services.
• American Vision Partners: PE-backed ophthalmology platform operating multiple specialty eye-care practices in the Southwest; comparable as a multi-state provider of retina, cataract, and glaucoma services with similar referral-driven model.
• Bascom Palmer Eye Institute: University of Miami Health System's ophthalmology program (consistently top-ranked in the U.S.), directly competing for retina referrals in the same Miami geography; comparable as a leading vitreoretinal provider with academic research prestige.

Regional players

• Midwest Eye Institute: Indianapolis-based multi-specialty ophthalmology practice offering medical and surgical eye care; comparable in scale and service mix to a multi-physician specialty retina/surgical group, though operating in a different geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/retinamaculamiami
• LinkedInlinkedin.com/company/retina-macula-specialists-of-miami-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Macula